Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs SPDR Kensho Final Frontiers ETF (ROKT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs SPDR Kensho Final Frontiers ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.59 (market cap $6.04B), while SPDR Kensho Final Frontiers ETF trades at $103.71 (market cap $170.14M). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 35.5× SPDR Kensho Final Frontiers ETF's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, SPDR Kensho Final Frontiers ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and SPDR Kensho Final Frontiers ETF for 9 Days on average.
| IOVA | ROKT | |
|---|---|---|
Market Cap | $6.04B | $170.14M |
Volume | 14,805,993 | 12,298 |
Sector | Health | Sector/Thematic |
52-Week High | $14.82 | $136.68 |
52-Week Low | $1.81 | $72.93 |
Typical Hold Time | 0 Days | 9 Days |
Enterprise Value | $5.97B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About SPDR Kensho Final Frontiers ETF
SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →
